Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1338.50
3.10
(0.23%)
< Home
< Back
Dr. Reddys Laboratories Ltd. News
>>
Dr. Reddy's Laboratories’ arm incorporates wholly-owned subsidiary in Jamaica
>>
Dr. Reddy's Laboratories gets nod to incorporate Wholly-owned Subsidiary
>>
Dr. Reddy’s Laboratories informs about information on newspaper publication
>>
Dr. Reddy's Laboratories gains on launching Saxagliptin and Metformin Hydrochloride Extended-Release Tablets
>>
Dr. Reddy's Laboratories launches Saxagliptin and Metformin Hydrochloride Extended-Release Tablets
>>
Dr. Reddy's Laboratories gains on reporting 18% rise in Q1 consolidated net profit
>>
Dr. Reddy's Laboratories reports 18% rise in Q1 consolidated net profit
>>
Dr. Reddy's Lab - Quaterly Results
>>
Dr. Reddy's Lab reports Profit after tax of Rs 16394.00 Mln, in the June 2023 quarter
>>
Dr. Reddy's Lab - Quaterly Results
<<
<
22
23
24
...145
>
>>